vs
Cooper Companies (The)（COO）与Masco（MAS）财务数据对比。点击上方公司名可切换其他公司
Masco的季度营收约是Cooper Companies (The)的1.8倍（$1.9B vs $1.1B），Masco净利率更高（11.9% vs 7.9%，领先3.9%），Masco同比增速更快（6.5% vs 4.6%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -4.2%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
美国家居建材企业Masco主营家装及新建住宅市场相关产品，旗下拥有20余家子公司，在全球运营近80座生产工厂，其中美国本土近60座，海外地区超20座。公司1969年于纽交所挂牌上市，后实现快速增长，成功跻身美国财富500强榜单。
COO vs MAS — 直观对比
营收规模更大
MAS
是对方的1.8倍
$1.1B
营收增速更快
MAS
高出1.9%
4.6%
净利率更高
MAS
高出3.9%
7.9%
两年增速更快
COO
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.9B |
| 净利润 | $84.6M | $228.0M |
| 毛利率 | 61.1% | 35.8% |
| 营业利润率 | 13.2% | 16.5% |
| 净利率 | 7.9% | 11.9% |
| 营收同比 | 4.6% | 6.5% |
| 净利润同比 | -28.0% | 14.5% |
| 每股收益（稀释后） | $0.42 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOMAS
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $1.1B | $1.9B | ||
| Q2 25 | $1.0B | $2.1B | ||
| Q1 25 | $964.7M | $1.8B | ||
| Q4 24 | $1.0B | $1.8B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $942.6M | $2.1B |
净利润COOMAS
| Q1 26 | — | $228.0M | ||
| Q4 25 | $84.6M | $165.0M | ||
| Q3 25 | $98.3M | $189.0M | ||
| Q2 25 | $87.7M | $270.0M | ||
| Q1 25 | $104.3M | $186.0M | ||
| Q4 24 | $117.5M | $182.0M | ||
| Q3 24 | $104.7M | $167.0M | ||
| Q2 24 | $88.9M | $258.0M |
毛利率COOMAS
| Q1 26 | — | 35.8% | ||
| Q4 25 | 61.1% | 33.9% | ||
| Q3 25 | 65.3% | 34.2% | ||
| Q2 25 | 67.8% | 37.6% | ||
| Q1 25 | 68.4% | 35.8% | ||
| Q4 24 | 66.5% | 34.8% | ||
| Q3 24 | 66.1% | 36.6% | ||
| Q2 24 | 67.0% | 37.5% |
营业利润率COOMAS
| Q1 26 | — | 16.5% | ||
| Q4 25 | 13.2% | 13.8% | ||
| Q3 25 | 16.6% | 15.8% | ||
| Q2 25 | 18.4% | 20.1% | ||
| Q1 25 | 18.9% | 15.9% | ||
| Q4 24 | 19.5% | 15.9% | ||
| Q3 24 | 19.2% | 18.0% | ||
| Q2 24 | 17.2% | 19.0% |
净利率COOMAS
| Q1 26 | — | 11.9% | ||
| Q4 25 | 7.9% | 9.2% | ||
| Q3 25 | 9.3% | 9.9% | ||
| Q2 25 | 8.7% | 13.2% | ||
| Q1 25 | 10.8% | 10.3% | ||
| Q4 24 | 11.5% | 10.0% | ||
| Q3 24 | 10.4% | 8.4% | ||
| Q2 24 | 9.4% | 12.3% |
每股收益（稀释后）COOMAS
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | $0.81 | ||
| Q3 25 | $0.49 | $0.90 | ||
| Q2 25 | $0.44 | $1.28 | ||
| Q1 25 | $0.52 | $0.87 | ||
| Q4 24 | $0.59 | $0.85 | ||
| Q3 24 | $0.52 | $0.77 | ||
| Q2 24 | $0.44 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | $2.9B |
| 股东权益账面价值 | $8.2B | $27.0M |
| 总资产 | $12.4B | $5.2B |
| 负债/权益比越低杠杆越低 | 0.30× | 109.07× |
8季度趋势，按日历期对齐
现金及短期投资COOMAS
| Q1 26 | — | — | ||
| Q4 25 | $110.6M | $647.0M | ||
| Q3 25 | $124.9M | $559.0M | ||
| Q2 25 | $116.2M | $390.0M | ||
| Q1 25 | $100.9M | $377.0M | ||
| Q4 24 | $107.6M | $634.0M | ||
| Q3 24 | $109.7M | $646.0M | ||
| Q2 24 | $112.4M | $398.0M |
总债务COOMAS
| Q1 26 | — | $2.9B | ||
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | $2.9B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — |
股东权益COOMAS
| Q1 26 | — | $27.0M | ||
| Q4 25 | $8.2B | $-185.0M | ||
| Q3 25 | $8.4B | $-78.0M | ||
| Q2 25 | $8.3B | $-84.0M | ||
| Q1 25 | $8.1B | $-254.0M | ||
| Q4 24 | $8.1B | $-279.0M | ||
| Q3 24 | $7.9B | $-88.0M | ||
| Q2 24 | $7.8B | $-26.0M |
总资产COOMAS
| Q1 26 | — | $5.2B | ||
| Q4 25 | $12.4B | $5.2B | ||
| Q3 25 | $12.4B | $5.3B | ||
| Q2 25 | $12.4B | $5.3B | ||
| Q1 25 | $12.2B | $5.1B | ||
| Q4 24 | $12.3B | $5.0B | ||
| Q3 24 | $12.1B | $5.3B | ||
| Q2 24 | $12.0B | $5.4B |
负债/权益比COOMAS
| Q1 26 | — | 109.07× | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | 1.8% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOMAS
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $418.0M | ||
| Q3 25 | $261.4M | $456.0M | ||
| Q2 25 | $96.2M | $306.0M | ||
| Q1 25 | $190.6M | $-158.0M | ||
| Q4 24 | $268.1M | $407.0M | ||
| Q3 24 | $207.5M | $416.0M | ||
| Q2 24 | $111.0M | $346.0M |
自由现金流COOMAS
| Q1 26 | — | — | ||
| Q4 25 | $149.9M | $371.0M | ||
| Q3 25 | $164.5M | $415.0M | ||
| Q2 25 | $18.1M | $270.0M | ||
| Q1 25 | $101.2M | $-190.0M | ||
| Q4 24 | $128.1M | $351.0M | ||
| Q3 24 | $118.5M | $378.0M | ||
| Q2 24 | $36.9M | $303.0M |
自由现金流率COOMAS
| Q1 26 | — | — | ||
| Q4 25 | 14.1% | 20.7% | ||
| Q3 25 | 15.5% | 21.6% | ||
| Q2 25 | 1.8% | 13.2% | ||
| Q1 25 | 10.5% | -10.5% | ||
| Q4 24 | 12.6% | 19.2% | ||
| Q3 24 | 11.8% | 19.1% | ||
| Q2 24 | 3.9% | 14.5% |
资本支出强度COOMAS
| Q1 26 | — | 1.8% | ||
| Q4 25 | 9.2% | 2.6% | ||
| Q3 25 | 9.1% | 2.1% | ||
| Q2 25 | 7.8% | 1.8% | ||
| Q1 25 | 9.3% | 1.8% | ||
| Q4 24 | 13.7% | 3.1% | ||
| Q3 24 | 8.9% | 1.9% | ||
| Q2 24 | 7.9% | 2.1% |
现金转化率COOMAS
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 2.53× | ||
| Q3 25 | 2.66× | 2.41× | ||
| Q2 25 | 1.10× | 1.13× | ||
| Q1 25 | 1.83× | -0.85× | ||
| Q4 24 | 2.28× | 2.24× | ||
| Q3 24 | 1.98× | 2.49× | ||
| Q2 24 | 1.25× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
MAS
暂无分部数据
